ArticlePloS one2017

Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.

Mohamed El Missiry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.